Occurrence of donor-derived CLL 8 years after sibling donor SCT for CML

Bone Marrow Transplantation

Volumn 42, Issue 10, 2008, Pages 687-688

  Perz, J B ^a   Ritgen, M ^b   Moos, M ^a   Ho, A D ^a   Kneba, M ^b   Dreger, P ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; CYCLOSPORIN A; IMMUNOGLOBULIN HEAVY CHAIN; METHOTREXATE; STEROID;

ACUTE GRAFT VERSUS HOST DISEASE; ADULT; AGED; CASE REPORT; CHROMOSOME DELETION; CHRONIC GRAFT VERSUS HOST DISEASE; CHRONIC LYMPHATIC LEUKEMIA; CHRONIC MYELOID LEUKEMIA; CYTOGENETICS; FEMALE; GENE MUTATION; GENE SEQUENCE; HUMAN; IMMUNOGLOBULIN HEAVY CHAIN GENE; IMMUNOPHENOTYPING; KARYOTYPE; LETTER; LEUKOCYTE COUNT; LEUKOCYTOSIS; LYMPHOCYTOSIS; MUTATION RATE; PHILADELPHIA 1 CHROMOSOME; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; SHORT TANDEM REPEAT; SIBLING; STEM CELL TRANSPLANTATION; WHOLE BODY RADIATION;

FEMALE; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE; MIDDLE AGED; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; SIBLINGS; TISSUE DONORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 57049140513     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2008.230     Document Type: Letter

References (7)

1. Ritgen M, Stilgenbauer S, von Neuhoff N, Humpe A, Brüggemann M, Pott C et al. Graft-versus-leukemia activity may overcome therapeutic resistance of chronic lymphocytic leukemia with unmutated immunoglobulin variable heavy-chain gene status: Implications of minimal residual disease measurement with quantitative PCR. Blood 2004; 104: 2600-2602.
2. Hertenstein B, Hambach L, Bacigalupo A, Schmitz N, McCann S, Slavin S et al. Chronic Leukaemia Working Party of the European Group for Blood and Marrow Transplantation. Development of leukemia in donor cells after allogeneic stem cell transplantation-a survey of the European Group for Blood and Marrow Transplantation (EBMT). Haematologica 2005; 90: 969-975.
3. Pavletic SZ, Zhou G, Sobocinski K, Marti G, Doney K, DiPersio J et al Genetically identical twin transplantation for chronic lymphocytic leukemia. Leukemia 2007; 21: 2452-2455.
4. Cooley LD, Sears DA, Udden MM, Harrison WR, Baker KR. Donor cell leukemia: Report of a case occurring 11 yeras after allegeneic bone marrow transplantation and review of the literature. Am J Hematol 2000; 63: 46-53.
5. Spinelli O, Giussani U, Borleri G, Lazzari M, Michelato A, Dotti G et al. Need for an accurate molecular diagnosis to assess the donor origin of leukemia relapse after allogeneic stem cell transplantation. Haematologica 2000; 85: 1153-1157.
6. Reichard KK, Zhang QY, Sanchez L, Hozier J, Viswanatha D, Foucar K. Acute myeloid leukemia of donor origin after allogeneic bone marrow transplantation for precursor T-cell acute lymphoblastic leukemia: Case report and review of the literature. Am J Hematol 2006; 81: 178-185.
7. Flynn CM, Kaufman DS. Donor cell leukemia: Insight into cancer stem cells and the stem cell niche. Blood 2007; 109: 2688-2692.